Literature DB >> 22917743

Evaluation of the inflammatory response in experimentally induced synovitis in the horse: a comparison of recombinant equine interleukin 1 beta and lipopolysaccharide.

T N Ross1, J D Kisiday, T Hess, C W McIlwraith.   

Abstract

OBJECTIVE: To compare two transient models of synovitis-osteoarthritis (OA) in horses by characterizing biological changes in synovial fluid and joint tissue.
METHOD: Twelve skeletally mature mares were utilized in a block design. Synovitis was induced by an intra-articular injection of 100 ng recombinant equine interleukin 1 beta (reIL-1β) or 0.5 ng lipopolysaccharide (LPS) into a middle carpal joint in 1 ml volumes. One ml of saline was injected into the contra-lateral control joint. Lameness evaluations were conducted through post-injection hour (PIH) 8 (at which time arthroscopic removal of synovium and articular biopsies was done), and at PIH 240. Arthrocentesis collection of synovial fluid occurred between PIH 0 and 48. An arthroscopic examination at PIH 8 included synovium and articular cartilage biopsies for gene expression analysis.
RESULTS: Synovial fluid analysis indicated that single injections of reIL-1β or LPS increased synovial white blood cell (WBC), neutrophil count, total protein, prostaglandin E(2) (PGE(2)) concentrations and general matrix metalloproteinase (MMP) activity relative to control joints through PIH 8. Injections of either reIL-1β or LPS increased mRNA expression for MMP-1 and a disintegrin and metalloprotease with thrombospondin motifs (ADAMTS)-4 in synovium and for MMP-1, ADAMTS-4, ADAMTS-5 in articular cartilage collected at PIH 8 compared to saline injections.
CONCLUSION: Injections of reIL-1β into equine carpal joints resulted in a transient inflammatory response that was similar in severity to the LPS injection, causing increased expression of certain deleterious mediators in joint tissues at 8 h. Given that IL-1β is a known critical mediator of traumatic arthritis and OA, this humane and temporary model may be useful in evaluating therapeutics that act against early stages of joint disease.
Copyright © 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22917743     DOI: 10.1016/j.joca.2012.08.008

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  19 in total

1.  Intra-articular delivery of a nanocomplex comprising salmon calcitonin, hyaluronic acid, and chitosan using an equine model of joint inflammation.

Authors:  Svenja Sladek; Clodagh Kearney; Daniel Crean; Pieter A J Brama; Lidia Tajber; Karolina Fawcett; Margot C Labberte; Bernadette Leggett; David J Brayden
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

2.  Is blood neutrophil-lymphocyte ratio an independent predictor of knee osteoarthritis severity?

Authors:  Özlem Taşoğlu; Hüma Bölük; Şule Şahin Onat; İrfan Taşoğlu; Neşe Özgirgin
Journal:  Clin Rheumatol       Date:  2016-01-16       Impact factor: 2.980

3.  Investigation of synovial fluid lubricants and inflammatory cytokines in the horse: a comparison of recombinant equine interleukin 1 beta-induced synovitis and joint lavage models.

Authors:  Amanda Watkins; Diana Fasanello; Darko Stefanovski; Sydney Schurer; Katherine Caracappa; Albert D'Agostino; Emily Costello; Heather Freer; Alicia Rollins; Claire Read; Jin Su; Marshall Colville; Matthew Paszek; Bettina Wagner; Heidi Reesink
Journal:  BMC Vet Res       Date:  2021-05-12       Impact factor: 2.741

4.  mRNA expression of genes involved in inflammation and haemostasis in equine fibroblast-like synoviocytes following exposure to lipopolysaccharide, fibrinogen and thrombin.

Authors:  Stine Mandrup Andreassen; Lise C Berg; Søren Saxmose Nielsen; Annemarie T Kristensen; Stine Jacobsen
Journal:  BMC Vet Res       Date:  2015-06-27       Impact factor: 2.741

5.  Autologous processed plasma: cytokine profile and effects upon injection into healthy equine joints.

Authors:  Juliana J Moreira; Ana Paula L Moraes; Patrícia M Brossi; Thaís S L Machado; Yara M Michelacci; Cristina O Massoco; Raquel Y A Baccarin
Journal:  J Vet Sci       Date:  2014-09-30       Impact factor: 1.672

6.  Single and repeated intra-articular injections in the tarsocrural joint with allogeneic and autologous equine bone marrow-derived mesenchymal stem cells are safe, but did not reduce acute inflammation in an experimental interleukin-1β model of synovitis.

Authors:  Aimée C Colbath; Steven W Dow; Leone S Hopkins; Jennifer N Phillips; C Wayne McIlwraith; Laurie R Goodrich
Journal:  Equine Vet J       Date:  2020-02-14       Impact factor: 2.888

7.  Synoviocytes protect cartilage from the effects of injury in vitro.

Authors:  Christina M Lee; John D Kisiday; C Wayne McIlwraith; Alan J Grodzinsky; David D Frisbie
Journal:  BMC Musculoskelet Disord       Date:  2013-02-01       Impact factor: 2.362

8.  Bacterial lipopolysaccharides form procollagen-endotoxin complexes that trigger cartilage inflammation and degeneration: implications for the development of rheumatoid arthritis.

Authors:  Wolfgang Lorenz; Constanze Buhrmann; Ali Mobasheri; Cora Lueders; Mehdi Shakibaei
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

9.  Carprofen inhibits the release of matrix metalloproteinases 1, 3, and 13 in the secretome of an explant model of articular cartilage stimulated with interleukin 1β.

Authors:  Adam Williams; Julia R Smith; David Allaway; Pat Harris; Susan Liddell; Ali Mobasheri
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

10.  Ex vivo effect of gold nanoparticles on porcine synovial membrane.

Authors:  Raphael Labens; B Duncan X Lascelles; Anna N Charlton; Nicole R Ferrero; Arnaud J Van Wettere; Xin-Riu Xia; Anthony T Blikslager
Journal:  Tissue Barriers       Date:  2013-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.